Towards cell replacement therapy in Parkinson’s disease. Proteoglycans and Nogo-A as modulators of axonal growth in midbrain dopaminergic neurons
Popular Abstract in English Parkinson’s disease (PD) is the second most common, after Alzheimer’s disease, neurodegenerative disease in man. Stiffness in joints, shaky hands, and slowness of movements make it difficult for people with PD to complete normal daily tasks like buttoning up a shirt. Additionally, PD affects memory, mood, sleep and the function of the gastro-intestinal tract. Over time,Parkinson’s disease (PD) is currently the second most common neurodegenerative disorder (after Alzheimer’s disease). PD is diagnosed on its motor symptoms, which include akinesia, bradykinesia, rigidity, postural imbalance and resting tremor. It is well established that the motor symptoms develop due to lack of dopamine in the striatum. This is caused by progressive degeneration of dopaminergic ne